Cathay Biotech Inc.

Shanghai Stock Exchange 688065.SS

Cathay Biotech Inc. Return on Assets (ROA) for the year ending December 31, 2023: 1.95%

Cathay Biotech Inc. Return on Assets (ROA) is 1.95% for the year ending December 31, 2023, a -37.29% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Cathay Biotech Inc. Return on Assets (ROA) for the year ending December 31, 2022 was 3.10%, a -15.47% change year over year.
Cathay Biotech Inc. Return on Assets (ROA) for the year ending December 31, 2021 was 3.67%, a -2.65% change year over year.
Cathay Biotech Inc. Return on Assets (ROA) for the year ending December 31, 2020 was 3.77%, a -52.89% change year over year.
Cathay Biotech Inc. Return on Assets (ROA) for the year ending December 31, 2019 was 8.01%, a -16.91% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Shanghai Stock Exchange: 688065.SS

Cathay Biotech Inc.

CEO	Dr. Xiucai Liu
IPO Date	Aug. 12, 2020
Location	China
Headquarters	Building #5
Employees	1,803
Sector	Health Care
Industries Biotechnology

Description

Cathay Biotech Inc. engages in the production and sale of bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. The company is headquartered in Shanghai, China.

Key trends

Past 5 years